Loading clinical trials...

Application of ICG Fluorescence Cholangiography in Laparoscopic Living Donor Left Lateral Sectionectomy | Clinical Trials | Clareo Health

COMPLETEDNA

Application of ICG Fluorescence Cholangiography in Laparoscopic Living Donor Left Lateral Sectionectomy

Retrospective Study on the Application of ICG Fluorescence Cholangiography in Laparoscopic Living Donor Left Lateral Sectionectomy

NCT05506020•Fudan University

View on ClinicalTrials.gov

Summary

The purpose of this study was to assess the effects of indocyanine green (ICG) fluorescence cholangiography during laparoscopic left lateral sectionectomy (LLLS) on the occurrence of biliary complications in both donors and recipients in living donor liver transplantation (LDLT) and to explore the optimal dose and injection time of ICG.

Detailed Description

This was a retrospective cohort study. The purpose of this study was to assess the effects of indocyanine green (ICG) fluorescence cholangiography during LLLS on the occurrence of biliary complications in both donors and recipients. The optimal dose and injection time of ICG were also investigated. From October 2016 to May 2022, the clinical data of 85 donors who underwent LLLS and relevant recipients in the Department of General Surgery of Huashan Hospital were retrospectively analyzed. According to whether ICG fluorescence cholangiography was used, they were divided into a non-ICG group (n=46) and an ICG group (n=39). Biliary complications were observed and the optimal dose and injection time of ICG were explored.

Eligibility

Age

All ages

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•1. From October 2016 to May 2022, donors and their corresponding recipients underwent laparoscopic donor liver acquisition surgery in the general surgery department of Huashan Hospital.
•2. Donor age ≥ 18 years old, regardless of gender; The receptor is the corresponding receptor of the donor, and the age and sex of the receptor are unlimited.
•3. The medical history is complete, which can meet the requirements of this study.
•4. Volunteer to participate in this study.

Exclusion Criteria

•1. The medical history is incomplete, which cannot meet the requirements of this study.
•2. The donor or recipient expressly refused to participate in this study.

Key Dates

Start Date

October 1, 2016

Primary Completion Date

May 1, 2022

Completion Date

July 1, 2022

Last Updated

August 18, 2022

Enrollment

ACTUAL participants

Conditions

Living Donor Liver Transplantation

Interventions

indocyanine green (ICG) fluorescence cholangiography

PROCEDURE

Delayed Infusion of DCreg in Living Donor Liver Transplantation

NCT04208919

Living Donor Liver Transplantation

View study

ACTIVE_NOT_RECRUITING

Biliary Complication Rates in Living Donor Liver Transplantation: a Retrospective Comparative Study of Stent Versus Non-Stent Groups

NCT06767553

Liver FailureLiving Donor Liver Transplantation+2 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 18, 2022Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Application of ICG Fluorescence Cholangiography in Laparoscopic Living Donor Left Lateral Sectionectomy

Inclusion Criteria

Exclusion Criteria

Delayed Infusion of DCreg in Living Donor Liver Transplantation

Biliary Complication Rates in Living Donor Liver Transplantation: a Retrospective Comparative Study of Stent Versus Non-Stent Groups

Efficacy of Loco-regional Treatment for Hepatocellular Carcinoma Prior to Living Donor Liver Transplantation in Egypt

Pressure Controlled Versus Volume Controlled Mechanical Ventilation During Anesthesia for Living Donor Liver Transplantation Recipients

Population Pharmacokinetics of Fentanyl in Patients Undergoing Living Donor Liver Transplantation